Research
Hormonal
Semaglutide offers robust cardiovascular protection.
Clinicians can consider semaglutide for patients needing cardiovascular protection in obesity management.
StrongSupportsmedium confidence
Semaglutide offers robust cardiovascular protection.
Why this rating
The claim is based on a comparative analysis of clinical trials.
Source
Tirzepatide vs. semaglutide: clinical decision-making in the GLP-1 landscape
Alvin Mondoh et al. · Expert Opinion on Pharmacotherapy · 2025
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →